← European Medicine Shortage Tracker · all medicines
Imipenem, cilastatin and relebactam currently has availability issues reported in 1 European register: Greece.
Limited availability ATC J01DH56 · also listed as: Imipenem, cilastatin and relebactam · data refreshed 7 August 2026
As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Imipenem, cilastatin and relebactam, covering 1 affected product presentation. The longest-running open report was filed in Greece on 2026-06-29 and has now been open for about 2 months. The furthest expected-resolution date currently on file is 2026-09-03; the earliest is 2026-09-03. In the WHO ATC classification, Imipenem, cilastatin and relebactam is coded J01DH56 — a medicine acting on anti-infectives for systemic use — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇬🇷 Greece | Limited availability Imipenem, cilastatin and relebactam | 2026-06-29 | 2026-09-03 | διαδικασία τις ίδιες ενδείξεις Εναλλακτικά άλλα σκευάσματα της ίδιας δ | register ↗ |
Every individual register entry for Imipenem, cilastatin and relebactam in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | Imipenem, cilastatin and relebactam | Limited availability | 2026-06-29 | 2026-09-03 | διαδικασία τις ίδιες ενδείξεις Εναλλακτικά άλλα σκευάσματα τ |
Yes. As of 7 August 2026, availability issues are reported in: Greece. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-03 to 2026-09-03. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
Directly from the official medicines-agency register that lists Imipenem, cilastatin and relebactam: EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Imipenem, cilastatin and relebactam — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/imipenem-cilastatin-and-relebactam/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Imipenem, cilastatin and relebactam availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/imipenem-cilastatin-and-relebactam/">Imipenem, cilastatin and relebactam shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>